ProSeal™ CSTDs are the family of Closed System Transfer Devices (CSTDs) that mechanically prohibit environmental contaminants from entering the system and the escape of hazardous drug vapors from the system, thereby minimizing operator and patient exposure to hazardous drug vapors during compounding and patient drug administration.
ProSeal™ CSTD supports safe hazardous drug handling during compounding, transfer, delivery, and disposal. Its closed system and dry connection help reduce exposure risk, with vapour containment tested according to NIOSH guidelines.
ProSeal™ CSTD is easy to use with an easy-glide push-and-pull action. It helps reduce drug wastage through low residual volume, supports reuse with partially used vials for up to 168 hours / 7 days, and selected components are DMA Compatible.
ProSeal™ Injection Site and all its corresponding interface membranes exhibit 100% efficiency in achieving a dry connection in the communicating surfaces in a fluid transfer.
Microbial Ingress testing verifies container closure integrity for product sterility. ProSeal™ CSTD reliably prevents microbial ingress of at least 168 hours (7 days).
The ProSeal™ Vial Adaptor ensures pressure equalization when connected to a drug vial.
This prevents the generation of fine aerosols that could expose the environment, patients, and healthcare professionals to hazardous drugs, which may occur due to pressure differences.
Our comprehensive range of CSTD accessories elevate safety standards for healthcare professionals and patients alike.
ProSeal™ CSTDs are the family of Closed System Transfer Devices (CSTDs) that mechanically prohibit environmental contaminants from entering the system and the escape of hazardous drug vapors from the system, thereby minimizing operator and patient exposure to hazardous drug vapors during compounding and patient drug administration.
ToxiSeal™ Vial Adaptors mechanically prohibits environmental contaminants from entering the system and the escape of drug aerosols from the system, thereby minimizing operator and patient exposure to drug aerosols during compounding and patient drug administration.
